14097070 · Active · incorporated 4 years, 4 months ago · Great Abington
Biotech Deep Tech Drug Discovery Healthcare Series B+
T-Therapeutics is developing a pipeline of first-in-class drugs using biotechnology to create transformative medicines for cancer and autoimmune diseases.
T-Therapeutics Limited is a private limited company registered at Companies House under number 14097070, incorporated on 10 May 2022, with a registered office in Great Abington. Its current status on the register is active. Its filed nature of business covers research and experimental development on biotechnology (SIC 72110) and other research and experimental development on natural sciences and engineering (SIC 72190). Sonde has indexed 56 filings for this company, including 3 funding rounds. Its most recent round closed in October 2025, raising £42.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Oct 2025 | £42.2m | £0.10 |
| Round 2 | Mar 2024 | £15m | £0.70 |
| Round 1 | Nov 2022 | £15m | £0.70 |
Showing the 11 most recent of 56 filings.
See the complete cap table with every shareholder, founder tags, dilution across 21 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.